“Fundamental insights into microbial host-virus interactions led to the development of tools for genome editing using restriction enzymes or the revolutionary CRISPR-Cas technology. In this review, we provide a historical overview of milestones that led to the genome editing revolution […]
This is the fourth and final part of the “What’s different” series. It has been a very interesting read. It paints a picture of an exciting time for humanity. One excerpt that really grabbed me about AI and the power […]
The first two parts of this series were Sequencing and Synthesis. This part, called Scale, builds on the idea that the underlying breakthroughs enable automation that drives the pace of science much faster, creating totally new types of biotechnology. | learn more
Published on LessWrong, this is one of the more approachable summaries of the field. One exciting point: “Today, there are over 130 longevity biotechnology companies and over 50 anti-aging drugs in clinical trials in humans.” However, a commenter offers this […]